regadenoson has been researched along with Myocardial Infarction in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 8 (80.00) | 24.3611 |
| 2020's | 2 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Diep, L; Doukky, R; Iskander, F; Iskander, M; Kattoor, AJ; Khan, R; Kolkailah, AA | 1 |
| Akçakaya, M; Chen, KA; Farzaneh-Far, A; Hughes, A; Kazmirczak, F; Martin, CM; Nijjar, PS; Okasha, O; Shenoy, C; Zhang, L | 1 |
| Ahlberg, AW; Alter, EL; Duvall, WL; Felpel, KD; Gowdar, S; Henzlova, MJ; Perucki, WH; Rai, M; Savino, JA | 1 |
| Hsi, DH; Luft, U; Marreddy, R; Moshiyakhov, M | 1 |
| Parra, D; Rosenstein, RS; Shah, S | 1 |
| Bhave, NM; Cavanaugh, KP; Chandra, S; Czobor, P; Davidson, MH; Freed, BH; Lang, RM; Mor-Avi, V; Narang, A; Patel, AR; Tanaka, SM; Turner, KM; Zaran, ER | 1 |
| AlJaroudi, WA; Bleich, S; El-Hajj, S; Farag, A; Hage, FG; Iskandrian, AE; Manaoragada, P | 1 |
| Ali, A; AlJaroudi, W; Campagnoli, T; Doukky, R; Fughhi, I; Wassouf, M | 1 |
| Kawaji, K; Kramer, CM; Lang, RM; Mor-Avi, V; Nathan, S; Patel, AR; Patel, MB | 1 |
| Ahmed, A; Dean, PJ; Hage, FG; Heo, J; Iqbal, FM; Iskandrian, AE; Raslan, S | 1 |
1 trial(s) available for regadenoson and Myocardial Infarction
| Article | Year |
|---|---|
Prognostic value of heart rate response during regadenoson stress myocardial perfusion imaging in patients with end stage renal disease.
Topics: Causality; Comorbidity; Death, Sudden, Cardiac; Double-Blind Method; Exercise Test; Female; Heart Rate; Heart Rate Determination; Humans; Incidence; Kidney Failure, Chronic; Male; Middle Aged; Myocardial Infarction; Myocardial Perfusion Imaging; Prognosis; Purines; Pyrazoles; Risk Factors; Survival Rate; Tomography, Emission-Computed, Single-Photon; United States; Vasodilator Agents | 2016 |
9 other study(ies) available for regadenoson and Myocardial Infarction
| Article | Year |
|---|---|
The prognostic value of regadenoson SPECT myocardial perfusion imaging: The largest cohort to date.
Topics: Aged; Cohort Studies; Female; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Myocardial Perfusion Imaging; Prognosis; Purines; Pyrazoles; Retrospective Studies; Tomography, Emission-Computed, Single-Photon | 2021 |
Safety and prognostic value of regadenoson stress cardiovascular magnetic resonance imaging in heart transplant recipients.
Topics: Adult; Coronary Artery Disease; Female; Heart Transplantation; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Predictive Value of Tests; Purines; Pyrazoles; Reoperation; Retrospective Studies; Risk Factors; Treatment Outcome; Vasodilator Agents | 2019 |
Risk stratification with vasodilator stress SPECT myocardial perfusion imaging in patients with elevated cardiac biomarkers.
Topics: Aged; Biomarkers; Coronary Artery Disease; Exercise Test; Female; Heart Failure; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Myocardial Perfusion Imaging; Perfusion; Prognosis; Proportional Hazards Models; Purines; Pyrazoles; Risk Assessment; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Vasodilator Agents | 2020 |
Regadenoson induced acute ST-segment elevation myocardial infarction and multivessel coronary thrombosis.
Topics: Adenosine A2 Receptor Agonists; Adult; Coronary Thrombosis; Electrocardiography; Humans; Male; Myocardial Infarction; Myocardial Perfusion Imaging; Purines; Pyrazoles; Thrombosis; Treatment Outcome | 2013 |
Acute myocardial infarction during regadenoson myocardial perfusion imaging.
Topics: Adenosine A2 Receptor Agonists; Aged; Coronary Circulation; Electrocardiography; Exercise Test; Humans; Male; Myocardial Infarction; Myocardial Perfusion Imaging; Purines; Pyrazoles | 2013 |
Prognostic value of normal regadenoson stress perfusion cardiovascular magnetic resonance.
Topics: Adult; Aged; Contrast Media; Coronary Artery Disease; Female; Gadolinium DTPA; Hemodynamics; Humans; Infusions, Intravenous; Kaplan-Meier Estimate; Magnetic Resonance Imaging, Cine; Male; Middle Aged; Myocardial Infarction; Myocardial Perfusion Imaging; Myocardial Revascularization; Perfusion; Predictive Value of Tests; Prognosis; Purines; Pyrazoles; Risk Factors; Stroke Volume; Time Factors; Vasodilator Agents; Ventricular Function, Left | 2013 |
Effect of changes in perfusion defect size during serial regadenoson myocardial perfusion imaging on cardiovascular outcomes in high-risk patients.
Topics: Alabama; Comorbidity; Contrast Media; Coronary Artery Disease; Exercise Test; Female; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Myocardial Infarction; Myocardial Perfusion Imaging; Percutaneous Coronary Intervention; Prevalence; Prognosis; Purines; Pyrazoles; Reproducibility of Results; Risk Assessment; Sensitivity and Specificity; Survival Rate; Vasodilator Agents | 2016 |
Role of Perfusion at Rest in the Diagnosis of Myocardial Infarction Using Vasodilator Stress Cardiovascular Magnetic Resonance.
Topics: Adenosine; Aged; Chronic Disease; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Myocardial Infarction; Myocardial Perfusion Imaging; Purines; Pyrazoles; Rest; Retrospective Studies; Vasodilator Agents | 2016 |
Comparison of the prognostic value of normal regadenoson with normal adenosine myocardial perfusion imaging with propensity score matching.
Topics: Adenosine; Adenosine A2 Receptor Agonists; Aged; Cardiac-Gated Single-Photon Emission Computer-Assisted Tomography; Cause of Death; Chi-Square Distribution; Female; Heart Diseases; Humans; Incidence; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Myocardial Perfusion Imaging; Myocardial Revascularization; Predictive Value of Tests; Prognosis; Propensity Score; Proportional Hazards Models; Purines; Pyrazoles; Reference Values; Risk Factors; Stroke Volume; Time Factors; Vasodilator Agents; Ventricular Function, Left | 2012 |